Avid Bioservices Inc (CDMO)

[keep_trying]

Moby and Thurly, when PPHM has reported on results from trials, they have consistently highlighted the point that Bavi was "safe and well tolerated". My review of posts and references you exchanged indicates that safety is an ongoing investigation area for all trials. Since PPHM had demonstrated "safe and well tolerated", whether the safety reference is repeated in all citations seems irrelevant. That might be compared with the recent FDA review panel recommendations about Avastin, where overall performance, including safety/side effects were weighed into a post Phase 2 approval assessment.

Thanks for the exchange that affirms that Bavi has been demonstrating that it is safe and well tolerated and that both efficacy and safety are review parameters through various trial stages. I look forward to Bavi demonstrating results in the ongoing Phase 2b trials that can reinforce the India trial results, this time with the double blind trial protocol being practiced in a US trial.

Best wishes and IMO.
KT